ANI Pharmaceuticals Q3 Adj. EPS $2.70 Beats $2.18 Estimate, Sales $290.800M Beat $280.196M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.18 by 23.85 percent. This is a 32.35 percent increase over earnings of $2.04 per share
ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.18 by 23.85 percent. This is a 32.35 percent increase over earnings of $2.04 per share from the same period last year. The company reported quarterly sales of $290.800 million which beat the analyst consensus estimate of $280.196 million by 3.78 percent. This is a 27.65 percent increase over sales of $227.813 million the same period last year.